Triple Whammy - Linda Bryant

Linda Bryant talks about a dangerous drug trio known as the triple-whammy and the implications in general practice. Dr Bryant is a practising clinical pharmacist. She also teaches post graduate pharmacy students and is passionate about optimisation and individualisations of medicines therapy. She is chair of the clinical advisory pharmacist association and is currently on the medicines adverse reactions committee for MedSafe.

Topics

what is the triple-whammy and how does it increase the risk of renal failure?
how problematic is this in everyday clinical practice?
red flags
considerations in older people
monitoring patients
renal insufficiency, signs and symptoms
managing triple-whammy-induced renal impairment
advice to patients.

Take home messages

Is the combination really necessary?
Monitoring is important at week 1 and week 4.
Please report adverse events to Centre for Adverse Reactions Monitoring (CARM)
Emphasise to patient - do not take OTC non-steroidals.

Resources

Saferx.co.nz triple whammy fact sheet
SaferX Patient Information Guide (2016)
New Zealand Formulary
Polypharmacy in people aged 65 and over Health Quality & Safety Commission NZ

Patient Resources

Presenter

Linda Bryant

Clinical Pharmacist

To contact Linda Click here.

Recognition of Learning Activities

Don't forget to log your time with The Royal New Zealand College of General Practitioners portal for recognition of learning activities.

Log your CPD

The Goodfellow Unit podcast is funded in part by the Royal New Zealand College of General Practitioners.